{"statement_id": "RN001", "text": "A method for distinguishing agonistic anti-B7-H1 (PD-L1) antibodies from antagonistic anti-B7-H1 antibodies using a functional assay or binding characterization that differentiates antibodies that activate B7-H1 signaling from those that block B7-H1/PD-1 interactions, enabling selection of the appropriate antibody class for treating cancer, infectious disease, or autoimmune conditions.", "source_patent_id": "10302653", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10302653"], "ground_truth": {"tier1_relevant_docs": {"W2105567953": 2, "10259875": 1, "W2131577873": 1, "W2171853585": 2}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN002", "text": "Transgenic mice engineered to be deficient in adenosine deaminase (ADA), resulting in chronically elevated systemic adenosine levels, which serve as an animal model for studying and screening therapeutic compounds against pathological conditions caused by adenosine accumulation.", "source_patent_id": "6207876", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["6207876"], "ground_truth": {"tier1_relevant_docs": {"W2157741965": 1, "W2150598424": 3, "W1981488721": 1, "W1579364872": 1, "W2104052230": 1, "W1555490957": 1, "W2169344912": 3, "W2068147126": 1, "W2103872763": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN003", "text": "Double-stranded RNA molecules between 15 and 21 nucleotides in length that are complementary to a target gene sequence are used to inhibit expression of that target gene.", "source_patent_id": "8202980", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8202980"], "ground_truth": {"tier1_relevant_docs": {"8101584": 3, "8168776": 3, "8119608": 3, "W2045653120": 2, "8114851": 3, "8729037": 3, "10508277": 2, "9994853": 2, "8283329": 2, "8580754": 2, "9102939": 2, "W2002200554": 1, "W1567381189": 1, "10000754": 2, "10351852": 2, "10662428": 2, "10889815": 2, "9181551": 2, "9657294": 2, "9732344": 2, "9738899": 2, "9771588": 2, "9957517": 2, "10041068": 2, "W2087235070": 1, "W1906181797": 1, "W2103392842": 2, "W2038544294": 3, "W2114735542": 3, "W2094253263": 1, "W2056320912": 1, "W2324865838": 2, "W1984251559": 2, "W2113657260": 2, "W2144158368": 2, "W2034046707": 1, "W2021007708": 1, "W147652200": 2, "W1614759083": 1, "8604183": 2, "W1546832385": 1, "W2113513945": 3, "9260471": 3, "9970005": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN004", "text": "Modified mRNA polynucleotides encoding apoptosis inducing factor 1 (AIF1) incorporating chemical modifications to enhance stability and translational efficiency for therapeutic oncology applications.", "source_patent_id": "9301993", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9301993"], "ground_truth": {"tier1_relevant_docs": {"W2058647478": 2, "9220792": 1, "9095552": 1, "9255129": 1, "9114113": 1, "9149506": 1, "9216205": 2, "W1994983564": 1, "9050297": 1, "9107886": 1, "9675668": 1, "W1982010715": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN005", "text": "Small molecule glycomimetic compounds that function as E-selectin antagonists by inhibiting binding of E-selectin to its ligands, useful for treating cancer metastasis by blocking adhesion of cancer cells to bone marrow endothelial cells and inhibiting cancer cell infiltration into bone marrow.", "source_patent_id": "10526361", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10526361"], "ground_truth": {"tier1_relevant_docs": {"10766916": 3, "9109002": 3, "9796745": 3, "9867841": 2, "W1871629237": 3, "W2163318518": 1, "W2047942414": 3, "W2562574582": 2, "W2395243915": 1, "W1725142663": 2, "W2480666200": 2, "W2979826324": 2, "W2035480085": 1, "W2568387171": 2, "W4248903596": 2, "W2557946695": 3, "W2564443150": 3, "11072625": 2, "W2079365541": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN006", "text": "A method for treating viral or virally-induced conditions comprising orally administering a histone deacetylase (HDAC) inhibitor as a viral inducing agent in combination with an antiviral agent, wherein the HDAC inhibitor activates latent virus to render it susceptible to the antiviral agent.", "source_patent_id": "10857152", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10857152"], "ground_truth": {"tier1_relevant_docs": {"W1976555683": 1, "W2147447587": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN007", "text": "An anti-CGRP antagonist antibody (G1) that binds to calcitonin gene-related peptide and blocks its activity, used to prevent or treat CGRP-associated disorders including migraine, cluster headache, tension headache, and vasomotor symptoms such as hot flushes.", "source_patent_id": "9890210", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9890210"], "ground_truth": {"tier1_relevant_docs": {"9890211": 3, "10329343": 3, "9884907": 3, "9884908": 3, "10556945": 3, "9896502": 3, "9708393": 2, "10266587": 2, "11325967": 2, "W2676947678": 1, "W2782073995": 1, "W2040875763": 1, "W1992928272": 1, "W2075728979": 2, "10597448": 2, "W2152386859": 1, "W2607327290": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN008", "text": "Antibodies with high binding affinity specifically targeting the A\u03b2(20-42) globulomer epitope, wherein the antibodies recognize an epitope present on amyloid-beta globulomer conformational variants comprising residues 20-42 of the amyloid-beta peptide.", "source_patent_id": "9822171", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9822171"], "ground_truth": {"tier1_relevant_docs": {"8987419": 3, "9062101": 3, "10047121": 3, "10538581": 3, "8691224": 3, "9540432": 3, "W2120096591": 3, "8497072": 3, "W2119279113": 1, "W2056092494": 3, "W2126958454": 2, "W2104878642": 1, "W1996037698": 2, "8877190": 3, "9359430": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN009", "text": "An analyte sensing biointerface comprising a sensing electrode embedded within a non-conductive matrix that contains a plurality of discrete passageways extending through the matrix to provide direct fluidic access from tissue to the sensing electrode surface, enabling analyte detection in vivo.", "source_patent_id": "10702193", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10702193"], "ground_truth": {"tier1_relevant_docs": {"10376188": 3, "10667729": 3, "10667730": 3, "8060174": 3, "9788766": 3, "W1999007589": 1, "10143410": 1, "11147483": 1, "8583204": 1, "8682408": 1, "8954128": 1, "9173606": 1, "9173607": 1, "9549699": 1, "9566026": 1, "9572523": 1, "9693721": 1, "7881763": 1, "8277713": 1, "8509871": 2, "9328371": 1, "9804114": 1, "10022078": 3, "W2470426965": 1, "8118877": 2, "W2030153280": 1, "8840552": 2, "11102306": 1, "8229535": 1, "9020572": 1, "9143569": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN010", "text": "A dual-strip lateral flow assay device that simultaneously differentiates viral from bacterial infections by using a first chromatographic test strip to detect MxA protein and low-level C-reactive protein as viral infection markers, and a second chromatographic test strip to detect high-level C-reactive protein as a bacterial infection marker, operating on a fingerstick blood sample.", "source_patent_id": "10379121", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10379121"], "ground_truth": {"tier1_relevant_docs": {"10408835": 3, "10808287": 3, "W1982672647": 1, "W1601324395": 1, "W2089238012": 1, "W2041559574": 1, "W2160132348": 2, "W2322987389": 2, "W1997815596": 1, "W2038330119": 1, "W2112995567": 1, "W4232042142": 2, "W1991577015": 2, "W2110830588": 1, "W2092891003": 1, "W1992612216": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN011", "text": "Opioid antagonists, including peripherally restricted opioid antagonists, are used to attenuate endothelial cell proliferation and migration associated with angiogenesis, thereby inhibiting cancerous tumor growth and metastasis.", "source_patent_id": "8518962", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8518962"], "ground_truth": {"tier1_relevant_docs": {"8524731": 3, "9662325": 3, "9662390": 3, "9675602": 3, "9717725": 3, "W2579523544": 1, "W2735739709": 3, "W2127881618": 2, "W2031848709": 1, "W2095893831": 1, "W2164621617": 1, "W2322614519": 1, "W2074925725": 1, "W1903450321": 1, "W2172074189": 1, "W2095368589": 1, "W2994038732": 2, "W2156405505": 2, "W2123386346": 1, "W2110610344": 1, "W1895036842": 1, "W2406688330": 1, "W1985834247": 2, "W2184879005": 1, "10383869": 2, "8685995": 2, "9526723": 2, "W2552328241": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN012", "text": "A method for assessing immunocompetence by sequencing rearranged TCR and/or immunoglobulin DNA or RNA from a lymphoid sample to quantify adaptive immune receptor diversity and clonal distribution, wherein the resulting repertoire metrics are used to stratify patients by immune status and predict likelihood of response to immunotherapy.", "source_patent_id": "10221461", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10221461"], "ground_truth": {"tier1_relevant_docs": {"11180813": 3, "11047008": 1, "11066705": 2, "W3005826182": 2, "W2043071551": 2, "11214793": 2, "9809813": 2, "W80473510": 2, "W2085156070": 2, "W1551566597": 2, "9824179": 2, "10214770": 2, "9150905": 2, "9371558": 2, "10155992": 2, "10519511": 2, "10760133": 2, "10865453": 2, "11021757": 2, "9512487": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN013", "text": "A microfluidic device comprising a retention member that spatially separates particles from a liquid sample, and a pressure actuator that recombines at least some of the separated particles with a controlled subset of the separated liquid, enabling concentration or dilution of particle-containing samples on-chip, optionally followed by thermal lysis of the particles in an integrated lysing chamber.", "source_patent_id": "10865437", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10865437"], "ground_truth": {"tier1_relevant_docs": {"11078523": 3, "11135584": 1, "W1972867200": 1, "W2160035051": 1, "W2022234108": 1, "W2014512524": 1, "W1985054717": 1, "W2083106700": 1, "W2030235300": 1, "W2404051966": 1, "11084036": 1, "W2125741791": 1, "W2116428607": 1, "W1992057680": 1, "W2150929216": 1, "W2278136502": 1, "W2169868093": 1, "W3153050222": 1, "W2058016311": 1, "W1992723320": 1, "W4245840577": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN014", "text": "A method for identifying DNA methylation state by treating a target nucleic acid with a reagent that modifies nucleotides based on methylation state (e.g., bisulfite conversion), performing methylation-specific amplification of the treated target, fragmenting the amplified products by base-specific cleavage, and detecting the resulting fragments by mass spectrometry to identify the methylation state or precise locus of methylated or unmethylated nucleotides.", "source_patent_id": "9249456", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9249456"], "ground_truth": {"tier1_relevant_docs": {"W2098362718": 3, "W2074628531": 1, "W1970833628": 2, "W2082550660": 1, "W2106401558": 1, "W2117038014": 1, "W1994465394": 2, "W1970668422": 1, "W2089662278": 2, "W2099521252": 1, "W2160372366": 1, "W2130572312": 2, "W2111183991": 2, "W1636055145": 1, "W2106340111": 2, "W1567533051": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN015", "text": "An integrated receiver and hand-held medicament injection pen system wherein a continuous glucose sensor receiver calculates a medicament therapy and automatically sets a bolus dose on the injection pen, with the receiver and pen being either integrally formed or detachably connected via mutually engaging electrical contacts or wireless communication.", "source_patent_id": "9741139", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9741139"], "ground_truth": {"tier1_relevant_docs": {"10278580": 3, "10403012": 3, "10966609": 3, "11373347": 3, "8562558": 3, "8808228": 3, "11564602": 1, "7927274": 2, "8282550": 1, "9538946": 1, "10653835": 3, "10835672": 3, "11246990": 3, "7976492": 3, "8721585": 3, "8882741": 3, "8920401": 3, "8926585": 3, "9050413": 3, "9155843": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN016", "text": "A method of treating neuropsychiatric disorders, including schizophreniform disorder, by administering an effective amount of digestive enzymes (naturally or recombinantly derived) or their derivatives to reduce one or more symptoms of the neuropsychiatric disorder.", "source_patent_id": "10279016", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10279016"], "ground_truth": {"tier1_relevant_docs": {"10940187": 3, "10350278": 1, "11364287": 1, "11016104": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN017", "text": "A biointerface membrane for implantable devices comprising a first domain distal to the device that supports tissue ingrowth and attachment while inhibiting barrier cell layer formation, and a second domain proximal to the device that is resistant to cellular attachment and impermeable to cells, thereby preventing formation of a fibrous barrier that would impede analyte transport to the implanted device.", "source_patent_id": "8840552", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8840552"], "ground_truth": {"tier1_relevant_docs": {"8118877": 3, "10022078": 3, "W1984583685": 2, "7792562": 2, "7835777": 2, "7970448": 2, "7974672": 2, "8527025": 2, "8676288": 2, "9339223": 2, "8527026": 2, "8923947": 2, "9439589": 2, "9931067": 2, "W1988881359": 1, "10610140": 1, "8255030": 1, "8255033": 1, "9597027": 1, "9993186": 1, "W1586651582": 2, "W1974644354": 1, "W2146749893": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN018", "text": "Specific point mutations in NTRK1, NTRK2, and/or NTRK3 genes confer resistance to Trk inhibitors in cancer, and detection of these mutations in patient tumor samples can be used to predict Trk inhibitor efficacy, determine resistance risk, and guide treatment selection away from Trk inhibitor therapy.", "source_patent_id": "10655186", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10655186"], "ground_truth": {"tier1_relevant_docs": {"W2620626563": 2, "W2338990099": 3, "10724102": 3, "10907215": 3, "W2500669545": 2, "W2194998434": 3, "W2148089871": 2, "W2130348198": 1, "W2943991753": 1, "W2180425334": 1, "W2109269285": 1, "W2891473286": 1, "W2169013957": 1, "W4231572578": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN019", "text": "Nucleic acid sequencing method that uses Molecular Index Tags (MITs) attached to adapter sequences to uniquely label and identify individual sample nucleic acid molecules, enabling differentiation of distinct molecules with the same sequence during sequencing workflows.", "source_patent_id": "11519028", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11519028"], "ground_truth": {"tier1_relevant_docs": {"10011870": 3, "10577650": 3, "11530442": 3, "10221436": 1, "10557158": 1, "11414688": 1, "W2009039142": 2, "10077473": 2, "10526650": 2, "9708657": 3, "W2057536116": 1, "10829815": 1, "W987420839": 3, "W2303585199": 3, "11299774": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN020", "text": "An analytical test device comprising a base with a reaction area and visualization area, where analysis chemistry reagents include a nucleic acid substrate with a first label and a nucleic acid reactor that react with an analyte-containing sample to produce a labeled nucleic acid visualization species, which is then captured by a nucleic acid capture species in the visualization area, enabling lateral flow detection through nucleic acid-nucleic acid binding interactions.", "source_patent_id": "7799554", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["7799554"], "ground_truth": {"tier1_relevant_docs": {"W1988220558": 1, "W2135667690": 1, "W2074603803": 2, "11162132": 1, "11299774": 1, "11390912": 1, "11613773": 1, "6551784": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN021", "text": "Stable genetic transformation of maize cells is achieved by introducing the Streptomyces bar gene into embryogenic maize suspension culture cells via microprojectile bombardment, followed by selection of transformed cells using the herbicide bialaphos, and subsequent regeneration of fertile transformed maize plants from the selected cells.", "source_patent_id": "6399861", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6399861"], "ground_truth": {"tier1_relevant_docs": {"6803499": 3, "7705215": 3, "6329574": 3, "6025545": 3, "6777589": 3, "5990390": 3, "W2163621988": 3, "W2091843088": 2, "W1976290254": 1, "W1993993130": 1, "W2063673708": 1, "W2052839443": 1, "W2170434347": 1, "W4243845639": 3, "W2012129665": 2, "W2125582909": 2, "W2146611372": 2, "W1538806497": 1, "W1506529854": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN022", "text": "A truncated thrombomodulin derivative conjugated to polyethylene glycol (PEG) via site-specific pegylation, wherein the pegylation is directed to a defined site on the truncated thrombomodulin protein to produce a thrombomodulin conjugate with preserved protein C pathway regulatory activity.", "source_patent_id": "7833978", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["7833978"], "ground_truth": {"tier1_relevant_docs": {"W2057286297": 1, "W2034097744": 1, "W2051998923": 1, "W1990761369": 1, "W190138522": 1, "W2043817081": 1, "W2501177568": 1, "W1517078815": 2, "W2100513413": 1, "W1966603445": 1, "W2013074637": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN023", "text": "Recombinant microalgal cells engineered with exogenous genes encoding a combination of lipid-pathway enzymes\u2014including fatty acyl-ACP thioesterase, keto acyl-ACP synthase, and sucrose transporter/invertase\u2014to enable heterotrophic cultivation on sucrose while producing triacylglyceride compositions with tailored fatty acid profiles suitable for food, fuel, and oleochemical applications.", "source_patent_id": "9279136", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9279136"], "ground_truth": {"tier1_relevant_docs": {"9255282": 3, "10100341": 3, "9249436": 3, "8852885": 3, "10006034": 3, "10167489": 2, "10344305": 2, "9388435": 2, "9719114": 2, "10053715": 2, "8945908": 2, "9102973": 2, "9200307": 2, "10287613": 2, "10683522": 2, "11401538": 2, "9551017": 2, "9909155": 2, "9068213": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN024", "text": "A multispecific binding molecule comprising at least two polypeptide chains each containing a heavy chain portion and a synthetic connecting peptide, wherein the synthetic connecting peptide is designed to preferentially drive formation of interchain disulfide linkages over intrachain disulfide linkages, such that greater than 50% of the resulting dimers comprise polypeptide chains linked via at least one interchain disulfide bond rather than intrachain disulfide bonds.", "source_patent_id": "8084026", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8084026"], "ground_truth": {"tier1_relevant_docs": {"8603473": 3, "W1998744147": 2, "W1506651516": 1, "W1984670732": 1, "W2092638671": 1, "W2165739023": 1, "W1973382371": 1, "W1571113921": 2, "9889197": 2, "10093738": 2, "10093739": 2, "9284375": 2, "9296816": 2, "9963510": 2, "W1993370938": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN025", "text": "Recombinant human lysosomal acid lipase (LAL) engineered with specific glycosylation patterns that facilitate internalization into target cells via mannose or mannose-6-phosphate receptor-mediated uptake, for use in enzyme replacement therapy of lysosomal acid lipase deficiency conditions such as Wolman disease and cholesteryl ester storage disease.", "source_patent_id": "11560554", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11560554"], "ground_truth": {"tier1_relevant_docs": {"W1578923307": 2, "10407671": 3, "10858638": 3, "W2046407155": 3, "W2160241181": 1, "W1479884104": 2, "W2162765266": 3, "W2173535394": 1, "8945542": 2, "W1632247257": 2, "W2100842605": 1, "W172450680": 1, "W1976651057": 1, "W2462770198": 1, "W2157991447": 2, "W2418548215": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN026", "text": "A method for simultaneously amplifying multiple nucleic acid target loci in a single reaction volume using a library of primers selected to minimize formation of primer dimers and non-target amplicons, wherein the primer library selection process optimizes primer compatibility across all primer pairs to enable highly multiplexed PCR amplification.", "source_patent_id": "10793912", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10793912"], "ground_truth": {"tier1_relevant_docs": {"10316362": 3, "10351906": 3, "10526658": 3, "10538814": 3, "10557172": 3, "10597708": 3, "10597709": 3, "10597723": 3, "10655180": 3, "10731220": 3, "11111545": 3, "11286530": 3, "11312996": 3, "11332793": 3, "11390916": 3, "11519035": 3, "11525162": 3, "W2137167287": 2, "W2118555972": 2, "W2033609627": 2, "W2120335901": 2, "W2318103124": 2, "W2171719398": 2, "W2062837212": 1, "W2168585454": 2, "W2412513069": 2, "10214770": 2, "9150905": 2, "9371558": 2, "W2144175569": 1, "W2046001839": 1, "10894977": 2, "W2120504051": 1, "W2106888005": 2, "10647981": 1, "W2157463520": 2, "11072789": 1, "W2127442514": 1, "W2075922438": 2, "W2029233894": 1, "W2125811524": 1, "W2127082697": 1, "W2173498175": 2, "W2052383391": 2, "W2146351150": 1, "W2118811947": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN027", "text": "An automated digital assistant that, in response to a user's speech input, simultaneously presents both a verbatim text echo of the speech input based on its textual interpretation and a semantic paraphrase of the user's request based on its interpreted meaning, allowing the user to distinguish between what was heard and what was understood.", "source_patent_id": "8930191", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8930191"], "ground_truth": {"tier1_relevant_docs": {"9338493": 1, "9668024": 1, "10490187": 1, "8903716": 1, "10475446": 1, "9858925": 1, "8942986": 1, "10049663": 1, "11069347": 1, "10083690": 1, "10691473": 1, "11526368": 1, "9865280": 1, "9633674": 1, "11405466": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN028", "text": "Antibodies or antibody fragments that bind to an epitope located within the second cysteine-rich subdomain (Cys2, amino acid residues 1575-1725) of MUC5AC with high specificity and selectivity for pancreatic cancer, enabling therapy when conjugated to therapeutic agents such as 90Y and in vivo/in vitro detection and diagnosis of pancreatic cancer.", "source_patent_id": "9452228", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9452228"], "ground_truth": {"tier1_relevant_docs": {"W1544575922": 3, "W2077870908": 1, "W1975433606": 1, "W1982492189": 2, "W2115196893": 1, "W2130301749": 2, "W2038933154": 2, "W2133255804": 1, "W2085055581": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN029", "text": "A method for treating cancer by administering a Btk inhibitor to mobilize a lymphocyte subpopulation into blood, determining the expression profile of one or more biomarkers from that subpopulation via immunophenotyping, and then selecting and administering a second therapeutic agent based on the determined biomarker expression profile.", "source_patent_id": "10004746", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10004746"], "ground_truth": {"tier1_relevant_docs": {"10004745": 3, "10016435": 3, "10478439": 3, "10653696": 3, "10751342": 3, "9814721": 3, "10975442": 1, "11311576": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN030", "text": "A method for diagnosing pervasive developmental disorders (PDDs), dysautonomia, Parkinson's disease, and SIDS by analyzing a stool sample using immunoassay to detect antigens associated with specific pathogens including Giardia, Cryptosporidium, E. histolytica, C. difficile, Adenovirus, Rotavirus, or H. pylori as biological markers indicative of neurological condition risk or presence.", "source_patent_id": "10209253", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10209253"], "ground_truth": {"tier1_relevant_docs": {"W2118956834": 1, "10776453": 1, "7935799": 1, "W2102244140": 1, "W2008853677": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN031", "text": "A lentiviral vector comprising a combination of an inactivated central polypurine tract, a stuffer sequence encoding drug susceptibility genes, and a mutated hairpin in the 5\u2032 leader sequence that substantially abolishes replication, integrated within a self-inactivating vector configuration to enhance biosafety while maintaining efficient transgene expression for gene therapy applications.", "source_patent_id": "9260725", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9260725"], "ground_truth": {"tier1_relevant_docs": {"W2150922307": 1, "W1544190956": 1, "W2154853638": 2, "W2089579355": 2, "W2167523976": 2, "W2112824117": 1, "W2045812968": 1, "W1981449360": 1, "W1835972708": 2, "W2063548487": 1, "W2136355116": 2, "W2047942455": 1, "W2053601402": 1, "W2044474105": 1, "W2026901855": 1, "W2062826915": 1, "W2041709256": 1, "W1983804855": 1, "W2027296526": 1, "W2029727380": 1, "W2029571886": 1, "W2164835084": 1, "W1508974207": 1, "W1988849266": 1, "W2162361061": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN032", "text": "A method for treating metabolic disease by increasing expression of ILDR2 (Immunoglobulin-Like Domain Receptor 2) in a subject, wherein agents that upregulate ILDR2/Ildr2 RNA expression are identified by contacting cells with candidate compounds and comparing Ildr2 RNA expression levels in the presence and absence of the agent.", "source_patent_id": "9682123", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9682123"], "ground_truth": {"tier1_relevant_docs": {"W2117749980": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN033", "text": "Engineered immunostimulatory bacteria encoding RNAi molecules (shRNA or microRNA) that inhibit TREX1 (three prime repair exonuclease 1) expression, formulated for treating HPV-positive tumors or tumors with high tumor mutational burden where TREX1 expression correlates with tumor presence or properties.", "source_patent_id": "11242528", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["11242528"], "ground_truth": {"tier1_relevant_docs": {"W2119681037": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN034", "text": "A uricase-polymer conjugate wherein at least one branched polymer comprising a backbone with a plurality of covalently attached side chains is conjugated to uricase to reduce or eliminate the antigenicity of the uricase molecule.", "source_patent_id": "10392611", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10392611"], "ground_truth": {"tier1_relevant_docs": {"10364451": 3, "W1989411256": 2, "W1943625917": 3, "7815893": 1, "8475765": 1, "W2568016708": 1, "W2073471403": 1, "W2326355551": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN035", "text": "An ultrasound method that simultaneously tracks both vessel wall motion and blood flow velocity using high frame rate pulse-echo ultrasound data combined with speckle tracking applied to both the vessel wall and intraluminal blood, enabling concurrent characterization of vascular wall dynamics and flow patterns from a single acquisition sequence.", "source_patent_id": "11547384", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11547384"], "ground_truth": {"tier1_relevant_docs": {"W2110282218": 2, "W2098486499": 1, "W2544030031": 3, "W2096578443": 2, "W2098349201": 3, "W2153906642": 1, "W2140014467": 1, "W2006656297": 1, "W2072870956": 1, "W2153891623": 2, "W1975573633": 2, "W2112636735": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN036", "text": "Administering carbon monoxide gas to a subject in a therapeutically sufficient amount and duration treats ischemic disorders, with additional methods employing selectin antagonists to prevent white blood cell accumulation or inactivated Factor IX to inhibit coagulation as alternative treatments for ischemic disorders.", "source_patent_id": "8128963", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8128963"], "ground_truth": {"tier1_relevant_docs": {"W2160800132": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN037", "text": "Aluminum-coated glass slides with a metal oxide surface layer that enables covalent grafting of modified oligosaccharides, providing simultaneous fluorescence-based binding analysis and mass spectrometric characterization of carbohydrates on the same electrically conductive substrate with greater sensitivity than transparent glass slides.", "source_patent_id": "10274488", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10274488"], "ground_truth": {"tier1_relevant_docs": {"W2089319310": 3, "W1965423278": 3, "W2028085557": 1, "W2042650834": 1, "W1978481656": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN038", "text": "A touch keyboard input correction method that interprets a single contact motion spanning from a first position to a second position on a keyboard interface as a potentially ambiguous key selection, then ranks candidate words by computing probabilities that the motion was intended to select each of multiple different keys, using these per-key probabilities to order candidate word suggestions presented to the user.", "source_patent_id": "10101822", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10101822"], "ground_truth": {"tier1_relevant_docs": {"9785630": 1, "9798393": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN039", "text": "A continuous analyte sensor comprising a sensing membrane that includes at least one surface-active group-containing polymer configured as a bioprotective layer that substantially blocks the effect of non-constant noise-causing species on the sensing mechanism while allowing target analyte transport to the sensing mechanism.", "source_patent_id": "9693721", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9693721"], "ground_truth": {"tier1_relevant_docs": {"10143410": 3, "11147483": 3, "8583204": 3, "8682408": 3, "8954128": 3, "9173606": 3, "9173607": 3, "9549699": 3, "9566026": 3, "9572523": 3, "10376188": 1, "10667729": 1, "10667730": 1, "10702193": 1, "8060174": 1, "9788766": 1, "11102306": 1, "9020572": 1, "9143569": 1, "8229535": 1, "8277713": 1, "11160926": 1, "11350862": 1, "11382540": 1, "10231654": 1, "10478108": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN040", "text": "A transdermal drug delivery method using an occlusive patch to deliver cannabinoids\u2014including cannabidiol, cannabinol, nabilone, or specific THC derivatives\u2014in combination with specific permeation enhancers (propylene glycol monolaurate, diethylene glycol monoethyl ether, oleoyl macrogolglyceride, caprylocaproyl macrogolglyceride, or oleyl alcohol) to bypass gastrointestinal first-pass metabolism and treat illness symptoms in mammals.", "source_patent_id": "8449908", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8449908"], "ground_truth": {"tier1_relevant_docs": {"W2127383863": 1, "W2041250042": 1, "W2029366081": 1, "W49359531": 1, "W2133752997": 1, "W2108437852": 1, "W2128542220": 1, "W2095627608": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN041", "text": "An optical coherence tomography system that reduces speckle by using a sample arm arrangement that splits electromagnetic radiation into at least two beams and introduces a path length delay between the beams to irradiate a structure from different angles, enabling angular compounding through path length encoding to reduce speckle noise in the resulting OCT image.", "source_patent_id": "8559012", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8559012"], "ground_truth": {"tier1_relevant_docs": {"8174702": 3, "9226665": 3, "7995210": 1, "W1967985611": 2, "W2089238603": 1, "W2103457061": 2, "W1985263532": 1, "W2047015107": 1, "W2118216040": 1, "W2057535513": 1, "8175685": 1, "W2008322311": 1, "8922781": 1, "W2061240737": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN042", "text": "Poly(beta-amino alcohols) (PBAAs) synthesized via combinatorial polymerization serve as surface coatings that modulate inflammatory response in a structure-dependent manner, inhibiting macrophage activation in vitro and reducing inflammatory cell recruitment and fibrosis in vivo following subcutaneous implantation, and can form polyelectrolyte complex capsules for cellular encapsulation.", "source_patent_id": "9193827", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9193827"], "ground_truth": {"tier1_relevant_docs": {"W1995934164": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN043", "text": "Engineered cytochrome P450 BM-3 mutants (9-10A-A328V and 1-12G) created through directed evolution and site-directed mutagenesis that hydroxylate linear alkanes regioselectively at the 2-position using atmospheric dioxygen, producing opposite enantiomers of 2-octanol (S- and R-configured, respectively) with 40-55% enantiomeric excess and thousands of product turnovers, with activity retained in whole-cell E. coli biotransformations using endogenous cofactor supply.", "source_patent_id": "8741616", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8741616"], "ground_truth": {"tier1_relevant_docs": {"W2083112939": 3, "8343744": 3, "9145549": 3, "7863030": 3, "W2063112093": 2, "W2133834597": 2, "W4235414783": 1, "W2148331201": 1, "W1482005880": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN044", "text": "A T cell in which a recombinant nucleic acid sequence encoding a chimeric antigen receptor (CAR) is integrated at a specific genomic site such that CAR expression is driven by an endogenous T cell promoter, and wherein integration at that site simultaneously reduces or prevents expression of a functional endogenous T cell receptor (TCR) complex at the cell surface.", "source_patent_id": "11377637", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11377637"], "ground_truth": {"tier1_relevant_docs": {"10525083": 1, "W2134422640": 1, "W2047205338": 1, "W1976400767": 2, "11242375": 1, "W2008686180": 1, "W2087414558": 1, "W2105798223": 1, "W1607012924": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN045", "text": "Amino derivatives of EM-138 (a thalidomide-related compound) and their thalidomide precursors, analogs, metabolites, and hydrolysis products inhibit angiogenesis when administered orally, providing treatment for disease states resulting from pathological angiogenesis.", "source_patent_id": "6420414", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["6420414"], "ground_truth": {"tier1_relevant_docs": {"6469045": 2, "7723361": 2, "8143283": 2, "8039488": 3, "6114355": 2, "6518298": 2, "6228879": 2, "W1986847430": 1, "W2979953013": 1, "W2078385611": 1, "W2046965419": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN046", "text": "A blood glucose monitoring unit integrates a calibration unit that eliminates the need for user-entered calibration codes by automatically calibrating in vitro test strips, providing compatibility with codeless test strips within an analyte monitoring system.", "source_patent_id": "10201301", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10201301"], "ground_truth": {"tier1_relevant_docs": {"8346337": 3, "8920319": 3, "8688188": 3, "8915850": 3, "9326716": 3, "8465425": 3, "9078607": 3, "W2101926913": 1, "8160671": 1, "8249684": 1, "8428678": 1, "W2409954223": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN047", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modulation of transcription at a target DNA locus without cleaving the DNA, wherein the RNA-Cas9 complex is directed to a specific genomic site by the targeting sequence to modulate gene expression.", "source_patent_id": "10526619", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10526619"], "ground_truth": {"tier1_relevant_docs": {"10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10400253": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10533190": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN048", "text": "A continuous analyte sensor calibration system that uses reference data from a short-term implanted continuous analyte sensor to initially calibrate or update sensor data from a separately implanted long-term continuous analyte sensor, and alternatively uses pre-insertion benchtop testing reference data to provide initial calibration of sensor data without requiring in vivo reference measurements.", "source_patent_id": "10898114", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10898114"], "ground_truth": {"tier1_relevant_docs": {"10610135": 3, "10610136": 3, "10610137": 3, "10617336": 3, "10709364": 3, "10716498": 3, "10743801": 3, "10856787": 3, "10918316": 3, "10918317": 3, "10918318": 3, "10925524": 3, "11000213": 3, "11051726": 3, "7920906": 3, "8560037": 3, "8579816": 3, "8611978": 3, "9078608": 3, "9314196": 3, "9918668": 3, "10786185": 2, "7797028": 2, "7826981": 2, "8052601": 2, "8060173": 2, "8206297": 2, "8394021": 2, "8442610": 2, "8548553": 2, "8622905": 2, "8676287": 2, "8700117": 2, "8761856": 2, "8788006": 2, "8788008": 2, "8801612": 2, "8808182": 2, "9895089": 2, "10980461": 2, "10898113": 1, "8005524": 1, "8216139": 1, "8233958": 1, "8251906": 1, "8257259": 1, "8265725": 1, "8290561": 1, "8374667": 1, "8469886": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN049", "text": "A two-stage microfluidic cartridge that performs nucleic acid amplification in a first stage and then distributes amplified products to a second detection stage, enabling multiplexed detection of multiple target nucleic acids from a single amplification reaction within an integrated device.", "source_patent_id": "11453906", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11453906"], "ground_truth": {"tier1_relevant_docs": {"9598724": 1, "W2089922757": 2, "W2021031313": 1, "W2007192510": 1, "W2114840438": 2, "W2066346928": 1, "W2035285327": 2, "W106927097": 1, "10370705": 2, "9447461": 2, "W2094691790": 1, "W2087828704": 1, "W2016882071": 1, "11266987": 2, "W2145303234": 1, "W2071829817": 1, "W2074603803": 1, "W2123649638": 1, "W2142162336": 1, "W2164952035": 1, "7833708": 1, "8486636": 1, "10131934": 2, "W2137748829": 1, "W2149275456": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN050", "text": "A microfluidic device comprising a retention member that spatially separates particles from liquid in a particle-containing sample, and a pressure actuator that recombines the separated particles with only a subset of the separated liquid, thereby concentrating the particles, followed by thermal lysis of the concentrated particles in a lysing chamber to release their contents.", "source_patent_id": "11078523", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11078523"], "ground_truth": {"tier1_relevant_docs": {"10865437": 3, "W2150929216": 1, "W2404051966": 1, "W2014512524": 1, "W1985054717": 1, "W1992057680": 1, "W2065309676": 1, "W2083106700": 1, "W846227499": 1, "W2125741791": 1, "W2116428607": 1, "W1992723320": 1, "W2117573623": 1, "W2100953371": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN051", "text": "A genetically modified non-human animal whose genome comprises an endogenous EPO gene locus modified to express human erythropoietin (EPO), enabling humanized erythropoiesis modeling and in vivo screening for agents that modulate erythrocyte function or pathogen infection of erythrocytes.", "source_patent_id": "10463028", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10463028"], "ground_truth": {"tier1_relevant_docs": {"10123518": 1, "10785966": 1, "10785968": 1, "9901082": 1, "9986724": 1, "W1990285147": 1, "W154036014": 1, "W2063250903": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN052", "text": "Ligands bearing site-specific conjugated electron-donating substituents that form transition metal catalyst complexes with enhanced ATRP equilibrium constants, enabling atom transfer radical polymerization at low catalyst concentrations while maintaining linear molecular weight growth with monomer conversion and narrow molecular weight distributions.", "source_patent_id": "9533297", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9533297"], "ground_truth": {"tier1_relevant_docs": {"11174325": 1, "W2314034520": 2, "W2076174949": 1, "W2091665035": 1, "W1967812778": 1, "W2014690667": 2, "W2017313815": 2, "W2148804555": 2, "W2087177903": 2, "W2083431697": 1, "W2327846609": 1, "W2039274720": 1, "W1972569526": 1, "10072042": 1, "W2332767535": 1, "W2076910445": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN053", "text": "An optical coherence imaging detector system wherein at least one detector has an electrical integration time during which it receives a signal combining sample and reference electromagnetic radiation, where the signal includes a first portion exceeding a predetermined power threshold and an immediately adjacent second portion with power below the threshold that extends for more than 10% of the electrical integration time, enabling detection of partially illuminated integration periods to improve imaging performance.", "source_patent_id": "RE44042", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["RE44042"], "ground_truth": {"tier1_relevant_docs": {"9060689": 1, "7843572": 1, "8175685": 1, "8081316": 1, "9377290": 1, "9226660": 1, "9364143": 1, "7920271": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN054", "text": "A patient monitor that correlates acoustic breathing sound signals from a respiratory sensor with SpO2 oxygen saturation time series data from a pulse oximeter using a processor to automatically detect and classify multiple SpO2 pattern types associated with respiratory events.", "source_patent_id": "8862196", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8862196"], "ground_truth": {"tier1_relevant_docs": {"9042952": 2, "8932227": 1, "8365730": 2, "10532170": 1, "9044558": 2, "W2414128781": 1, "W2536127515": 1, "W4243470037": 2, "W77398999": 1, "W2005290650": 1, "8398555": 2, "W2408541533": 1, "W2098506383": 1, "W2070901983": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN055", "text": "A client device establishes a secure communication link with a target device by generating an address request, performing an address lookup to determine whether the target device supports secure communications based on whether the requested address is identified in a secure domain name lookup, and then enabling audio/video communications over the established secure link.", "source_patent_id": "9077694", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9077694"], "ground_truth": {"tier1_relevant_docs": {"9077695": 3, "8868705": 3, "10511573": 3, "9374346": 3, "8850009": 3, "8843643": 3, "9860283": 3, "8904516": 3, "9819649": 3, "9100375": 2, "9037713": 3, "9967240": 3, "9038163": 3, "9027115": 3, "9094399": 2, "8943201": 2, "9413766": 2, "9769128": 2, "10187387": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN056", "text": "A peptide amphiphile molecule comprising a peptide sequence that non-covalently binds TGF-\u03b21 and self-assembles into a gel scaffold in situ, which when combined with microfracture surgery localizes and retains chondrogenic growth factors to induce bone marrow mesenchymal stem cell chondrogenic differentiation and enhance articular cartilage regeneration.", "source_patent_id": "8450271", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8450271"], "ground_truth": {"tier1_relevant_docs": {"W2025439968": 3, "W2068969716": 1, "W2017544519": 1, "W1991415492": 1, "W2047103746": 1, "W2107814037": 1, "W2103765130": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN057", "text": "A continuous analyte sensor calibration system that evaluates sensor data stability over an initial time period before initiating calibration, then builds and updates a calibration set from matched sensor-reference data pairs using inclusion criteria to select optimal calibration pairs, while implementing fail-safe mechanisms that assess clinical acceptability of reference analyte data and calibration quality to validate estimated blood analyte values.", "source_patent_id": "8622905", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8622905"], "ground_truth": {"tier1_relevant_docs": {"10786185": 3, "7797028": 3, "7826981": 3, "8052601": 3, "8060173": 3, "8206297": 3, "8394021": 3, "8442610": 3, "8548553": 3, "8676287": 3, "8700117": 3, "8761856": 3, "8788006": 3, "8788008": 3, "8801612": 3, "8808182": 3, "9895089": 3, "10610135": 3, "10610136": 3, "10610137": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN058", "text": "Tissue culture plastic-adherent placental stem cells (PDAC) are administered systemically to treat neuropathic pain in an individual, leveraging the immunomodulatory and neuroregenerative properties of placenta-derived adherent cells as a cell-based therapeutic approach.", "source_patent_id": "9040035", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9040035"], "ground_truth": {"tier1_relevant_docs": {"W2102726602": 1, "W2126134953": 1, "10195233": 1, "10220059": 1, "10383898": 1, "9579351": 1, "W2923081322": 1, "W2070334783": 1, "W1968668812": 1, "W1501884562": 1, "W2550262023": 2, "W2074379284": 1, "W1990279811": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN059", "text": "A lipid-based transfection compound having a central heteroatom core (N, O, or S) linked via a bivalent organic radical to multiple hydrophobic chains (alkyl, alkenyl, or aryl groups) and polyamine head groups selected from spermiyl, spermidyl, guanidyl, or related polyamine moieties, wherein the linker optionally incorporates ether, ester, amide, or phosphate functionalities, designed to facilitate intracellular delivery of biologically active agents.", "source_patent_id": "9358300", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9358300"], "ground_truth": {"tier1_relevant_docs": {"8058068": 1, "W1988289069": 3, "W2063595779": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN060", "text": "A method for purifying nucleotide sugars from a reaction mixture by sequentially adjusting pH and applying membrane filtration with specific molecular weight cut-offs to selectively remove contaminants including phosphate groups, magnesium sulfate, sodium pyruvate, and tetrasodium pyrophosphate while retaining the desired nucleotide sugar product.", "source_patent_id": "8841439", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8841439"], "ground_truth": {"tier1_relevant_docs": {"W2030008758": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN061", "text": "A non-naturally occurring microbial organism engineered with both 4-hydroxybutanoic acid (4-HB) and 1,4-butanediol (BDO) biosynthetic pathways, wherein exogenous nucleic acids encoding enzymes including 4-hydroxybutanoate dehydrogenase, \u03b1-ketoglutarate decarboxylase, 4-hydroxybutyrate:CoA transferase, and aldehyde/alcohol dehydrogenase are expressed to enable direct microbial fermentation of 1,4-butanediol (BDO) from central metabolic intermediates succinyl-CoA or \u03b1-ketoglutarate.", "source_patent_id": "9487803", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9487803"], "ground_truth": {"tier1_relevant_docs": {"11371046": 3, "8357520": 3, "8969054": 3, "8067214": 3, "8889399": 3, "10273508": 3, "8129169": 3, "9434964": 3, "7858350": 3, "8129156": 3, "8178327": 3, "9175297": 3, "11401534": 3, "8129155": 2, "10662451": 2, "8530210": 3, "9222113": 2, "9988656": 3, "7947483": 2, "8048661": 1, "8377666": 3, "8377667": 3, "10087470": 1, "8445244": 1, "8637286": 1, "11085015": 3, "9677045": 3, "10487342": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN062", "text": "A method for synthesizing arrays of polymer sequences on a substrate by selectively exposing regions bearing photoremovable protecting groups to light to activate those regions, then coupling monomers that also carry photoremovable protecting groups, and repeating the cycle with different monomers to build up sequence arrays of desired length.", "source_patent_id": "6660234", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6660234"], "ground_truth": {"tier1_relevant_docs": {"6630308": 3, "6747143": 3, "6403957": 3, "6646243": 3, "6566495": 3, "W2086464766": 3, "6491871": 3, "W2157215461": 3, "W2071451059": 3, "W2029911544": 1, "W2012878989": 2, "W2032429811": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN063", "text": "A method of treating hypertriglyceridemia by administering a pharmaceutical composition comprising eicosapentaenoic acid (EPA) or a derivative thereof as the sole active ingredient, without docosahexaenoic acid (DHA), to reduce triglyceride levels in a subject while minimizing increases in LDL-cholesterol.", "source_patent_id": "8440650", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8440650"], "ground_truth": {"tier1_relevant_docs": {"10537544": 3, "10632094": 3, "11291643": 3, "8293727": 3, "8293728": 3, "8314086": 3, "8324195": 3, "8357677": 3, "8367652": 3, "8377920": 3, "8399446": 3, "8415335": 3, "8426399": 3, "8431560": 3, "8518929": 3, "8524698": 3, "8546372": 3, "10966968": 1, "10561631": 3, "11052063": 3, "10166209": 3, "10265290": 3, "10610508": 3, "10973797": 3, "11185525": 3, "9452151": 3, "10973796": 2, "9827219": 2, "11141399": 1, "10406130": 2, "10842765": 2, "10172818": 2, "11446269": 2, "10016386": 2, "10278935": 2, "10278936": 2, "10278937": 2, "10278938": 2, "10278939": 2, "9603826": 2, "9610272": 2, "9623001": 2, "9693984": 2, "9693985": 2, "9693986": 2, "9918954": 2, "9918955": 2, "10383840": 2, "10555924": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN064", "text": "Azido-BODIPY compounds and cyclooctyne-based fluorogenic probes that undergo azide-alkyne cycloaddition reactions to form triazolyl products, wherein the fluorogenic probes exhibit increased fluorescence upon reaction with azide- or alkyne-containing biomolecules, enabling activity-based detection and imaging of target biomolecules without requiring wash steps.", "source_patent_id": "10119972", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10119972"], "ground_truth": {"tier1_relevant_docs": {"W2062188984": 2, "W2002866108": 3, "W2022634915": 3, "W2030812749": 1, "W2046253638": 2, "W2076529491": 2, "W1980282352": 2, "W2021320094": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN065", "text": "Single-chain polypeptides comprising only the protease domain of a type II transmembrane serine protease (MTSP) are used in methods to identify compounds that modulate MTSP protease activity, along with novel MTSP family members designated MTSP3, MTSP4, and a form of MTSP6.", "source_patent_id": "7700341", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7700341"], "ground_truth": {"tier1_relevant_docs": {"7888092": 3, "W2144185179": 2, "W2119542456": 2, "W2140618597": 2, "W2049831508": 1, "W2102142823": 1, "W1538277030": 1, "W1992681586": 1, "W1969754678": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN066", "text": "A hybridization chain reaction (HCR) method wherein a full initiator sequence is split into two or more partial initiator fragments that individually cannot trigger HCR amplification, but when brought into proximity through target-mediated binding events reconstitute a complete initiator capable of triggering HCR signal amplification.", "source_patent_id": "11214825", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11214825"], "ground_truth": {"tier1_relevant_docs": {"10450599": 3, "W2148304424": 1, "W1561752765": 1, "W2066649475": 1, "W2149270432": 1, "W2594994723": 1, "W2075077797": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN067", "text": "Small molecule glycomimetic compounds that antagonize E-selectin by inhibiting its binding to E-selectin ligands, thereby preventing cancer cell adhesion to bone marrow endothelial cells, reducing metastatic infiltration into bone marrow, and inhibiting thrombus formation.", "source_patent_id": "9109002", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9109002"], "ground_truth": {"tier1_relevant_docs": {"10526361": 3, "10766916": 3, "9796745": 3, "9867841": 2, "W2035480085": 1, "W1871629237": 2, "W2047942414": 3, "W1725142663": 2, "W2979826324": 2, "W2480666200": 2, "W1983774546": 2, "W2568387171": 2, "W4248903596": 2, "W2557946695": 2, "W2109466573": 2, "W2564443150": 2, "W2079365541": 1, "W2562574582": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN068", "text": "Fc region-containing polypeptides (preferably antibodies) comprising at least one amino acid substitution in the Fc region that attenuates post-translational fucosylation, thereby improving binding to activating Fc\u03b3 receptors and reducing binding to inhibitory Fc\u03b3 receptors to enhance effector cell function.", "source_patent_id": "9096877", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9096877"], "ground_truth": {"tier1_relevant_docs": {"W2127214162": 2, "W2168313542": 2, "W1973718144": 1, "W1989010611": 1, "W2143562636": 2, "W1529809181": 2, "W2036609771": 2, "8674083": 2, "W2053175240": 1, "W2051652916": 2, "W2170516337": 1, "W1969824500": 1, "W2046380830": 1, "8216574": 2, "W2058775948": 1, "9051373": 1, "10711069": 2, "8652466": 2, "9708408": 2, "W2418388414": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN069", "text": "Modified relaxin polypeptides comprising one or more amino acid substitutions with non-naturally encoded amino acids and/or conjugation to a water-soluble polymer such as polyethylene glycol, for use in treating fibrotic disorders or heart failure with improved pharmacological properties compared to native relaxin.", "source_patent_id": "9567386", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9567386"], "ground_truth": {"tier1_relevant_docs": {"11311605": 3, "10751391": 3, "11185570": 3, "8735539": 3, "10266578": 3, "11364281": 3, "10702588": 3, "9488660": 1, "W2030661378": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN070", "text": "Three-dimensional perfunctionalized polyhedral borane and carborane molecular clusters wherein all vertices of the polyhedral cage are substituted with functional groups, enabling manipulation of photophysical properties for use as photooxidants or organic light-emitting diode components.", "source_patent_id": "11479470", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["11479470"], "ground_truth": {"tier1_relevant_docs": {"W2146023678": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN071", "text": "Tocopherol quinone derivatives bearing fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, or amine substituents at the 1,4-benzoquinone core are used to treat oxidative stress disorders including mitochondrial disorders, neurodegenerative diseases, and diseases of aging by modulating, normalizing, or enhancing energy biomarkers.", "source_patent_id": "10703701", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10703701"], "ground_truth": {"tier1_relevant_docs": {"W2185348657": 1, "W1998801948": 1, "W2140075873": 1, "W1983904065": 1, "W2568450381": 1, "W2175835252": 1, "W617988207": 1, "W384863521": 1, "W2105754268": 1, "W2077447747": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN072", "text": "Bifunctional degrader molecules (Degronimers) comprising a glutarimide-based E3 ubiquitin ligase-binding degron linked to a target protein ligand via a carbon-carbon bond at the C3 position of the glutarimide ring, enabling targeted intracellular protein degradation through the ubiquitin-proteasome pathway.", "source_patent_id": "10849982", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10849982"], "ground_truth": {"tier1_relevant_docs": {"W2767426216": 2, "W2559947248": 1, "W2025031463": 1, "W2054746486": 1, "W2585495993": 1, "W2318148969": 2, "W2781383440": 2, "W2090958270": 1, "W1565619051": 2, "W2176682109": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN073", "text": "A therapeutic combination comprising temsirolimus (an mTOR inhibitor), trastuzumab (HER2-targeting monoclonal antibody), and/or HKI-272 (neratinib, an irreversible pan-HER tyrosine kinase inhibitor) for treating metastatic breast cancer, wherein the combination simultaneously targets the mTOR pathway, HER2 receptor, and HER family kinase signaling.", "source_patent_id": "10729672", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10729672"], "ground_truth": {"tier1_relevant_docs": {"W2113762115": 2, "W2124648931": 2, "W2018022997": 1, "W2016506024": 2, "W1965766554": 1, "W2133325068": 3, "W2104239861": 1, "W155262670": 1, "W2089071484": 1, "W2093650262": 2, "W2090648424": 1, "W2114195503": 2, "W2562573190": 1, "W2055831769": 2, "W2417773149": 1, "W2032942530": 1, "W2139135964": 1, "10111868": 1, "9511063": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN074", "text": "A method for measuring protein kinetic parameters (synthesis, breakdown, transport rates) in inaccessible tissues without physical tissue biopsy by administering isotope-labeled molecules in vivo, then collecting body fluid samples to isolate and measure isotopic incorporation patterns of tissue-derived proteins that have escaped into the body fluid via mass spectrometry, using the body fluid protein kinetics as a surrogate for the corresponding tissue protein kinetics.", "source_patent_id": "9134319", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9134319"], "ground_truth": {"tier1_relevant_docs": {"W2274357590": 1, "W2118922221": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN075", "text": "A field effect transistor for RF and microwave circuits incorporates one or more strained channel layers disposed on one or more planarized substrate layers, wherein the strained material configuration produces improved transconductance and noise figure characteristics suitable for use in voltage controlled oscillators, low noise amplifiers, and phase locked loops.", "source_patent_id": "7709828", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["7709828"], "ground_truth": {"tier1_relevant_docs": {"7906776": 3, "7776697": 2, "7846802": 2, "7884353": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN076", "text": "A non-naturally occurring microorganism engineered to produce acrylate via a biosynthetic pathway comprising a decarboxylase enzyme, wherein one or more gene disruptions reduce competing enzymatic activities to confer increased acrylate production, with at least one exogenous nucleic acid encoding the acrylate pathway enzyme expressed in sufficient amount to produce acrylate from fumarate or malate intermediates.", "source_patent_id": "8129154", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8129154"], "ground_truth": {"tier1_relevant_docs": {"7947483": 1, "10087470": 1, "8445244": 1, "8637286": 1, "10273508": 1, "8129169": 1, "9434964": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN077", "text": "A system for light-directed spatially-addressable parallel chemical synthesis that combines solid-phase chemistry, photolabile protecting groups, and photolithographic binary masking techniques to synthesize large-scale combinatorial chemical libraries on a substrate surface for receptor-ligand binding affinity screening.", "source_patent_id": "6491871", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6491871"], "ground_truth": {"tier1_relevant_docs": {"6566495": 3, "W2159511216": 3, "W2017423606": 1, "W2032429811": 3, "W2012878989": 2, "W2467395778": 1, "W2039492060": 1, "W2034413905": 1, "W2111130831": 1, "W2094850820": 1, "W33352663": 1, "W2142278025": 1, "W2022243850": 1, "W2157215461": 2, "W2086464766": 3, "W2053036921": 1, "W4251565960": 2, "W2036914780": 1, "W2029911544": 2, "W1983646492": 1, "W2166602500": 1, "W2027571016": 1, "W2010630649": 1, "W2899848970": 1, "W2952319396": 1, "W2022942432": 1, "W2035730261": 1, "W2071451059": 3, "10052605": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN078", "text": "Outer membrane vesicles (OMVs) containing polysaccharide A (PSA) are used as a delivery vehicle to mucous membranes, wherein the PSA-containing OMVs induce differentiation of functional regulatory T cells (Tregs) with suppressive activity in a PSA-dependent manner and prevent experimental colitis by suppressing pro-inflammatory cytokine responses in the gut.", "source_patent_id": "11419887", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11419887"], "ground_truth": {"tier1_relevant_docs": {"W2150968312": 2, "W2050259218": 1, "W2111951615": 1, "W1747012886": 1, "W2086454098": 1, "W2049449911": 1, "W1995097896": 1, "W2402098026": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN079", "text": "A method of inhibiting bone resorption comprising administering a sclerostin inhibitor to a human in an amount sufficient to reduce bone resorption marker levels for at least 2 weeks, wherein the sclerostin inhibitor is a sclerostin binding agent that can be monitored by measuring bone resorption markers before and after administration.", "source_patent_id": "9089553", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9089553"], "ground_truth": {"tier1_relevant_docs": {"10273293": 3, "11091537": 3, "W2073558178": 1, "W1970864109": 1, "W2339561542": 1, "W1992159640": 2, "W2075010531": 1, "8563271": 2, "8992911": 2, "9011856": 2, "9657095": 2, "W2108403721": 1, "W2112292482": 1, "7868134": 2, "W2087560312": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN080", "text": "A recombinant Listeria strain that expresses a tumor-specific antigenic polypeptide and optionally an angiogenic polypeptide, wherein a nucleic acid encoding at least one polypeptide is genomically integrated in-frame with a nucleic acid sequence encoding a PEST-containing polypeptide, enabling dual delivery of heterologous antigens to induce an immune response against cancer.", "source_patent_id": "9650639", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9650639"], "ground_truth": {"tier1_relevant_docs": {"9644212": 3, "8128922": 1, "9758551": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN081", "text": "An optical coherence tomography system that extends imaging depth range through optical sub-sampling, wherein a sample is characterized over a plurality of continuous resolvable depth points that exceeds the number of distinct measurements acquired, enabling depth reconstruction beyond the conventional Nyquist-limited imaging range without increasing detector sampling density.", "source_patent_id": "8937724", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8937724"], "ground_truth": {"tier1_relevant_docs": {"W1973494603": 1, "W2027077159": 2, "W2057925466": 1, "W2062630097": 1, "W2081934600": 1, "W2075929857": 1, "W2066456957": 1, "W2115794463": 1, "W2085637023": 3, "8081316": 1, "9226660": 1, "W2078920062": 1, "W2062786827": 1, "W1989548263": 1, "W2087670896": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN082", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modulation of transcription of a target DNA without cleaving the DNA, wherein the RNA-directed targeting is achieved through a guide RNA that directs the Cas9 polypeptide to a specific genomic locus to activate or repress transcription.", "source_patent_id": "10597680", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10597680"], "ground_truth": {"tier1_relevant_docs": {"10400253": 3, "10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10526619": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN083", "text": "A method for directed differentiation of mammalian definitive endoderm cells into gastric fundus tissue or organoids through a defined sequence of signaling pathway manipulations in vitro, producing tissue that recapitulates the cellular composition and organization of the gastric fundus.", "source_patent_id": "11066650", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11066650"], "ground_truth": {"tier1_relevant_docs": {"10174289": 3, "11053477": 3, "10947510": 1, "W1914028229": 1, "10351820": 1, "W2417077905": 1, "10233421": 1, "9593305": 1, "9593306": 1, "9506036": 1, "9528090": 1, "9951314": 1, "W2427010667": 2, "W1653176923": 1, "W2170781656": 1, "W2007260996": 1, "10781425": 1, "W2080741429": 1, "W2139020188": 1, "W2006838330": 1, "W2567003412": 1, "W2147705631": 1, "W1999914688": 1, "W2016093088": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN084", "text": "Bispecific antibodies comprising both a T cell-interacting region and a glycan-interacting region that binds sialyl Tn (STn) antigen expressed on cancer cells, enabling recruitment of T cells to STn-expressing cancer cells to mediate targeted cell killing.", "source_patent_id": "11401330", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11401330"], "ground_truth": {"tier1_relevant_docs": {"W2062675346": 1, "W2111742915": 1, "W2038444690": 1, "W2032185672": 2, "W2887482676": 1, "W1972848082": 1, "W1977743020": 1, "W2116215875": 1, "W1979077811": 1, "W2112689808": 1, "W2145132368": 1, "W2741768127": 3, "W2530534210": 1, "W1544375765": 1, "W1972130286": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN085", "text": "Fully human monoclonal antibodies that cross-reactively bind to both IL-17A and IL-17F, including their homodimeric forms and the heterodimeric IL-17A/IL-17F protein complex, for use in therapeutic, diagnostic, and prophylactic applications.", "source_patent_id": "8771697", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8771697"], "ground_truth": {"tier1_relevant_docs": {"8715669": 3, "9475873": 2, "8137671": 2, "8609093": 2, "W1801000534": 1, "W2091653067": 2, "W1551727579": 1, "W1974228120": 1, "W2132938540": 1, "W2147150779": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN086", "text": "Recombinant microalgal cells engineered with exogenous genes encoding combinations of lipid biosynthesis and modification enzymes\u2014including fatty acyl-ACP thioesterase, keto acyl-ACP synthase, fatty acyl-CoA reductase, and fatty aldehyde decarbonylase\u2014together with sugar utilization genes such as sucrose transporter, sucrose invertase, and fructokinase, enabling heterotrophic cultivation on low-cost sucrose feedstocks to produce tailored oils with specific fatty acid profiles suitable for renewable diesel, biodiesel, and jet fuel.", "source_patent_id": "9255282", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9255282"], "ground_truth": {"tier1_relevant_docs": {"10100341": 3, "9249436": 3, "9279136": 3, "8852885": 3, "10006034": 3, "10167489": 2, "10344305": 2, "9388435": 2, "9719114": 2, "10053715": 2, "8945908": 2, "9102973": 2, "9200307": 2, "10287613": 2, "10683522": 2, "11401538": 2, "9551017": 2, "9909155": 2, "9068213": 2, "8951777": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN087", "text": "Methods for treating anemia, low or intermediate-1-risk myelodysplastic syndromes (MDS), and/or non-proliferative chronic myelomonocytic leukemia (CMML) comprising administering Activin-ActRII signaling inhibitors that block the activin-ActRII signaling pathway to a subject in need thereof, thereby reducing or eliminating the need for red blood cell transfusions.", "source_patent_id": "11471510", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["11471510"], "ground_truth": {"tier1_relevant_docs": {}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN088", "text": "A combination therapy for cancer treatment comprising an anti-AXL antibody-drug conjugate (ADC) administered together with a secondary therapeutic agent, wherein the anti-AXL ADC targets the AXL receptor tyrosine kinase to deliver a cytotoxic payload to tumor cells.", "source_patent_id": "10544223", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10544223"], "ground_truth": {"tier1_relevant_docs": {"W2124514746": 1, "W2083670340": 1, "W2152976222": 1, "W2061537048": 1, "W2615326416": 1, "W2132089284": 1, "W2104998312": 1, "W2100314556": 1, "W2314837202": 1, "W2136750953": 1, "W2587678059": 1, "W1999146917": 1, "W2403458189": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN089", "text": "Antibodies that specifically bind to sclerostin (a TGF-beta binding protein) to interfere with the interaction between sclerostin and bone morphogenetic proteins (TGF-beta superfamily members), thereby increasing bone mineral density for treatment of conditions such as osteoporosis and osteopenia.", "source_patent_id": "9011856", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9011856"], "ground_truth": {"tier1_relevant_docs": {"8563271": 3, "8992911": 3, "9657095": 3, "7868134": 3, "W2075010531": 2, "W2073558178": 2, "W2112292482": 1, "W2087560312": 1, "W2016251348": 1, "W2339561542": 2, "W2032956576": 2, "W1970864109": 1, "10273293": 2, "11091537": 2, "9089553": 2, "W2108403721": 2, "W2039302262": 2, "W2160306549": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN090", "text": "Heteroaryl-substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-b]pyrimidine compounds that selectively modulate Janus kinase (JAK) activity, useful for treating immune-related diseases, skin disorders, myeloid proliferative disorders, and cancer by inhibiting JAK signaling pathways.", "source_patent_id": "9814722", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9814722"], "ground_truth": {"tier1_relevant_docs": {"10398699": 3, "10639310": 3, "11331320": 3, "8946245": 3, "9206187": 3, "9662335": 3, "9974790": 3, "11213528": 2, "10370387": 1, "11161855": 1, "9216984": 2, "9623029": 2, "10899736": 2, "9221845": 2, "9487521": 3, "9714233": 2, "9718834": 2, "10513522": 1, "11214573": 1, "9611269": 1, "9193733": 2, "10640506": 2, "9249145": 1, "9334274": 2, "10695337": 1, "11285140": 1, "9464088": 1, "9999619": 1, "10329299": 1, "9828377": 1, "W2019402966": 2, "W114839291": 1, "W1982421421": 1, "W4299639679": 1, "W2167617907": 1, "W2044086940": 1, "W2141032550": 1, "W2566221528": 1, "W2316411171": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN091", "text": "A method of inducing or modulating reward- or aversive-related behaviors in an animal by expressing light-responsive opsins in neurons projecting to the ventral tegmental area and selectively activating or inhibiting those neural inputs using optical stimulation to control dopaminergic circuit activity.", "source_patent_id": "9636380", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9636380"], "ground_truth": {"tier1_relevant_docs": {"9238150": 1, "W2416279662": 1, "10046174": 1, "W1980737345": 2, "W2083932518": 1, "W1990894640": 1, "W2165706889": 2, "W2013927030": 1, "10568307": 1, "W1980604666": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN092", "text": "A glucose sensor system that monitors a continuous data stream to detect transient non-glucose-related signal artifacts of higher amplitude than electronic or diffusion noise, and selectively replaces corrupted data by applying distinct signal estimation algorithms or distinct parameter sets to a single algorithm based on detected artifact severity, to minimize the impact of ischemia, pH changes, and temperature changes on reported glucose values.", "source_patent_id": "9750460", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9750460"], "ground_truth": {"tier1_relevant_docs": {"8346338": 3, "11589823": 3, "7998071": 3, "8010174": 3, "8073519": 3, "8073520": 3, "8128562": 3, "8150488": 3, "8167801": 3, "8195265": 3, "8229536": 3, "8292810": 3, "8412301": 3, "8435179": 3, "8491474": 3, "8790260": 3, "8795177": 3, "8812073": 3, "8821400": 3, "8843187": 3, "9149219": 3, "9649069": 3, "9724045": 3, "8777853": 3, "9420968": 3, "9510782": 3, "9585607": 3, "11564602": 1, "7927274": 1, "8282550": 1, "9538946": 1, "10898113": 2, "8005524": 2, "8216139": 2, "8233958": 2, "8251906": 2, "8257259": 2, "8265725": 2, "8290561": 2, "8374667": 2, "8469886": 2, "8657745": 2, "8747315": 2, "8801610": 2, "9107623": 2, "9192328": 2, "9351668": 2, "9364173": 2, "9498155": 2, "9750441": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN093", "text": "Antibodies or antigen-binding fragments thereof that immunospecifically bind to B Lymphocyte Stimulator (BLyS) protein, wherein these antibodies are used to prevent, treat, or ameliorate diseases or disorders associated with aberrant BLyS expression or inappropriate BLyS function by administering an effective amount to an animal.", "source_patent_id": "7879328", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7879328"], "ground_truth": {"tier1_relevant_docs": {"8101181": 3, "9187548": 3, "8062906": 3, "W2088324610": 1, "W2095460138": 2, "W1920115643": 1, "W1536748279": 3, "W2043971353": 1, "W2060208115": 3, "W2165056939": 1, "W2097129513": 1, "W2014956545": 2, "W1987554279": 1, "W212723289": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN094", "text": "A chimeric light-responsive membrane protein is created by modifying a rhodopsin nucleotide sequence with one or more heterologous adrenergic receptor subunits, enabling expression in a cell to produce secondary messengers (such as cAMP or IP3) in response to light stimulation rather than chemical ligands.", "source_patent_id": "8962589", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8962589"], "ground_truth": {"tier1_relevant_docs": {"9453215": 3, "10018695": 1, "10371776": 1, "10914803": 1, "9271674": 1, "9615789": 1, "10350430": 1, "W2034751180": 1, "W2165408978": 1, "9855442": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN095", "text": "A chimeric receptor comprising a cytoplasmic domain containing a 4-1BB stimulatory signaling domain that enables simultaneous signaling of both a primary activation pathway and a co-stimulatory pathway, allowing activation of the co-stimulatory pathway independently of binding to the natural 4-1BB ligand, expressed in T cells or NK cells.", "source_patent_id": "9856322", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9856322"], "ground_truth": {"tier1_relevant_docs": {"9834590": 3, "W2147051992": 1, "W1987891097": 1, "W1656949393": 1, "W2155754472": 1, "W2306413099": 2, "W2074129424": 1, "W2020646453": 3, "W2032803186": 3, "W1635113215": 1, "W1842126375": 3, "W2097765486": 1, "W1524274652": 1, "W83880277": 2, "W2789892520": 1, "W2564777138": 3, "W1514625873": 1, "W2050386410": 2, "W2036644325": 3, "W1499068539": 1, "W1943676235": 1, "W2159537998": 3, "W2053440339": 2, "W2099241614": 1, "W2144436556": 2, "W1574443686": 2, "W2556167380": 3, "W1834335942": 1, "W2161958391": 2, "W2176708322": 1, "W2406035635": 1, "W1615039363": 1, "W2165580475": 3, "W1596693997": 1, "W2111429442": 3, "10525083": 2, "W1989523156": 2, "W2131609628": 3, "W2014154395": 1, "W2160520392": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN096", "text": "A DNA sequencing method in which the four nucleotide bases are supplied individually and serially to a microfluidic reaction cell containing a DNA template and primer, with real-time detection of DNA polymerase-catalyzed incorporation events using fluorescence, chemiluminescence, or microcalorimetric measurement of heat generated during each nucleotide incorporation step.", "source_patent_id": "9957561", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9957561"], "ground_truth": {"tier1_relevant_docs": {"10214774": 3, "9096898": 3, "9212393": 3, "9540689": 3, "9725764": 3, "W2137348240": 2, "W2082631942": 2, "W2132341951": 1, "W2155466304": 1, "W2001590540": 1, "W1969628353": 1, "W2029297547": 1, "W80436974": 1, "W4234937123": 2, "W1987739795": 1, "W1964558738": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN097", "text": "Combined treatment of EGFR-mediated cancer using anti-EGFR monoclonal antibody mAb806 in combination with a src kinase inhibitor, wherein simultaneous or sequential inhibition of both EGFR and src pathways produces a therapeutic effect against cancer.", "source_patent_id": "9023356", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9023356"], "ground_truth": {"tier1_relevant_docs": {"9090693": 1, "W2087381093": 1, "W1969391810": 1, "W2052370726": 1, "W1991541715": 1, "W2032264569": 1, "W2267868684": 1, "W2144368667": 1, "W1556788203": 1, "W2143536404": 1, "W2139819066": 1, "W2099805317": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN098", "text": "A continuous analyte sensor comprising a sensing membrane that includes at least one surface-active group-containing polymer configured as a bioprotective layer that substantially blocks the effect of non-constant noise-causing species on the sensing mechanism while permitting analyte transport to the sensor.", "source_patent_id": "10143410", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10143410"], "ground_truth": {"tier1_relevant_docs": {"11147483": 3, "8583204": 3, "8682408": 3, "8954128": 3, "9173606": 3, "9173607": 3, "9549699": 3, "9566026": 3, "9572523": 3, "9693721": 3, "8229535": 1, "8277713": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN099", "text": "An implantable arrangement for stimulating target cells in vivo comprising an electrical light-generation means coupled to a biological portion containing a photosensitive bio-molecular arrangement, wherein the photosensitive bio-molecular arrangement responds to generated light by directly stimulating target cells within a living organism.", "source_patent_id": "10569099", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10569099"], "ground_truth": {"tier1_relevant_docs": {"10052497": 3, "10046174": 2, "10426970": 3, "10434327": 3, "9238150": 2, "9084885": 3, "9394347": 2, "W2037645743": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN100", "text": "A method of sequencing low-complexity amplicon libraries arrayed at high density on a surface, wherein amplicons are prepared using primer sets designed to ensure that initial sequencing-by-synthesis signals are evenly distributed among different nucleotides across different amplicons, thereby enabling accurate base calling in high-density random arrays where signal imbalance from low-complexity sequences would otherwise confound detection.", "source_patent_id": "10385475", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10385475"], "ground_truth": {"tier1_relevant_docs": {"W2318103124": 1, "W2060226894": 1, "W2027589602": 2, "W2143153669": 1, "W2168585454": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
